Blog
RSS FeedPosted by Michael Wonder on 05 Aug 2016
TGA publishes paper on transparency in medicines regulation
5 August 2016 - Co-authoring with the EMA, the TGA has published a peer-reviewed, free-to-view paper on transparency in medicines regulation. ...
Posted by Michael Wonder on 05 Aug 2016
TGA publishes AusPAR for Xiaflex
5 August 2016 - The TGA has published an AusPAR for Actelion's Xiaflex (collagenase clostridium histolyticum). ...
Posted by Michael Wonder on 03 Aug 2016
New biomedical fund to capitalise on our research and entrepreneurial strengths
3 August 2016 - A new fund to accelerate the development and commercialisation of Australian biomedical discoveries is now officially launched. ...
Posted by Michael Wonder on 01 Aug 2016
Appointment of CEO for the Australian Digital Health Agency
1 August 2016 - Minister for Health, Sussan Ley, has announced the appointment of Mr Tim Kelsey as the Chief Executive ...
Posted by Michael Wonder on 28 Jul 2016
TGA approves Afluria Quad
28 July 2016 - The TGA has approved CSL's Afluria Quad (quadrivalent influenza vaccine). ...
Posted by Michael Wonder on 28 Jul 2016
TGA approves Brenzys (etanercept)
28 July 2016 - The TGA has approved a biosimilar to Pfizer's Enbrel. ...
Posted by Michael Wonder on 28 Jul 2016
TGA approves Belkyra (deoxycholic acid)
28 July 2016 - The TGA has approved Allergan's Belkyra (deoxycholic acid). ...
Posted by Michael Wonder on 27 Jul 2016
AbbVie racks up three more indications for Humira
27 July 2016 - The TGA has approved three new indications for Abbvie's Humira (adalimumab). ...
Posted by Michael Wonder on 27 Jul 2016
TGA approves Targin (oxycodone hydrochloride with naloxone hydrochloride trihydrate) for new indication
27 July 2016 - The TGA has approved Mundipharma's Targin (oxycodone hydrochloride and naloxone hydrochloride trihydrate). ...
Posted by Michael Wonder on 27 Jul 2016
TGA finally approves Latisse (bimatoprost)
27 July 2016 - The TGA has approved a new use for Allergan's bimatoprost. ...
Posted by Michael Wonder on 18 Jul 2016
TGA cost recovery implementation statement 2016-17
18 July 2016 - This Cost Recovery Implementation Statement provides information on how the TGA implements cost recovery activities associated with ...
Posted by Michael Wonder on 07 Jul 2016
TGA approves Prometrium (progesterone)
7 July 2016 - The TGA has approved Besins Healthcare's Prometrium (progesterone). ...
Posted by Michael Wonder on 07 Jul 2016
TGA approves Descovy (emtricitabine with tenofovir alafenamide fumarate)
7 July 2016 - The TGA has approved Gilead Sciences' new dual combination product for patients with HIV infection. ...
Posted by Michael Wonder on 05 Jul 2016
TGA publishes AusPAR for asfotase alfa (Strensiq)
5 July 2016 - The TGA has published an AusPAR for Alexion Pharmaceuticals' Strensiq. ...
Posted by Michael Wonder on 05 Jul 2016
TGA publishes AusPAR for emtricitabine with elvitegravir and cobicistat and tenofovir alafenamide fumarate (Genvoya)
5 July 2016 - The TGA has published an AusPAR for Gilead's Genvoya. ...